Ultragenyx CEO talks the company’s path to profitability in developing drugs for rare diseases
Dr. Emil Kakkis, Ultragenyx founder & CEO, joins ‘Closing Bell Overtime’ to talk drug trials and development, its path to profitability and more.
Similar Posts
I am a better person: Sam Waksal
ShareShare Article via FacebookShare Article via TwitterShare Article via LinkedInShare Article via Email Squawk Box Sam Waksal, former Imclone Systems CEO, reveals how the ImClone scandal has impacted his life. 00:56 Tue, Jan 13 20158:36 AM EST Meg Tirrell
The number one thing we’re concerned about is summer traffic demand, says Cowen’s airline analyst
ShareShare Article via FacebookShare Article via TwitterShare Article via LinkedInShare Article via Email Helane Becker, Cowen, joins ‘Squawk on the Street’ to discuss what Delta’s earnings results say about the airline industry, what she’s watching and headwinds for the industry. 03:43 Mon, Apr 18 202211:40 AM EDT
AI is in focus at CES: What you need to know
CNBC’s Julia Boorstin joins ‘Power Lunch’ to discuss AI being in focus at CES.
Ret. U.S. Army Col. Jacobs on Red Sea tensions: The U.S. should attack the Houthi rebels in Yemen
ShareShare Article via FacebookShare Article via TwitterShare Article via LinkedInShare Article via Email Retired U.S. Army Col. Jack Jacobs joins ‘Squawk Box’ to discuss the latest developments in the Red Sea following recent large-scale attacks by Iran-backed Houthi rebels, what the U.S. response should be, the impact on U.S.-Iran tensions, and more. 05:10 Thu, Jan…
Crowdsourcing your bottom line
Internet lingerie startup “Adore Me” aims to disrupt the U.S. lingerie market. One strategy their using, is to crowdsource the designs they bring to market.
Citi’s restructuring will work this time, says Wells Fargo’s Mike Mayo
ShareShare Article via FacebookShare Article via TwitterShare Article via LinkedInShare Article via Email Closing Bell Mike Mayo, Wells Fargo bank analyst, joins ‘Closing Bell’ to discuss Citi’s Q4 warning, his bank earning predictions, and more. 05:16 7 minutes ago
